Androgen, estrogen, and progesterone receptor gene regulation during diabetic erectile dysfunction and insulin treatmentSHIRAI, Masato; YAMANAKA, Masaki; SHIINA, Hiroaki et al.Urology (Ridgewood, NJ). 2004, Vol 64, Num 6, pp 1244-1249, issn 0090-4295, 6 p.Article

Treatment of patients with superficial bladder cancer by intravesical instillation of anticancer drugs plus oral chemotherapy following TUR-Bt: A randomized controlled trialMATSUSHIMA, Hisashi; KAWABE, Kazuki; KAWAI, Tsuneo et al.Oncology reports. 2002, Vol 9, Num 2, pp 283-288, issn 1021-335XArticle

Ki26894, a novel transforming growth factor-β type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell lineEHATA, Shogo; HANYU, Aki; OGATA, Etsuro et al.Cancer science. 2007, Vol 98, Num 1, pp 127-133, issn 1347-9032, 7 p.Article

Loss of anti-apoptotic genes in aging rat cruraYAMANAKA, Masaki; SHIRAI, Masato; SHIINA, Hiroaki et al.The Journal of urology. 2002, Vol 168, Num 5, pp 2296-2300, issn 0022-5347Article

Increased Heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancerOGISHIMA, Tatsuya; SHIINA, Hiroaki; TERASHIMA, Masaharu et al.Clinical cancer research. 2005, Vol 11, Num 3, pp 1028-1036, issn 1078-0432, 9 p.Article

Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancerOGISHIMA, Tatsuya; SHIINA, Hiroaki; FUJIME, Makoto et al.Oncogene (Basingstoke). 2005, Vol 24, Num 45, pp 6765-6772, issn 0950-9232, 8 p.Article

Phase I/II clinical trials of carbon lontherapy for prostate cancerAKAKURA, Koichiro; TSUJII, Hirohiko; HARADA, Masaoki et al.The Prostate. 2004, Vol 58, Num 3, pp 252-258, issn 0270-4137, 7 p.Article